CHAMEDITECH introduced functional cosmetics ‘CELLTERMI REVIVE AFTERCARE’ targeting customers who received dermatological procedures or care at hospitals and clinics.

CELLTERMI REVIVE Aftercare uses pharmaceutical-based raw materials independently developed by CHAMEDITECH to manage temporarily weakened skin after skin treatment at a hospital.

This CELLTERMI REVIVE Aftercare, which is a renewal of the existing 'CELLTERMI RX' line, contains raw materials that CHAMEDITECH commercialized independently developed, such as NIDOGEN (CHA-Nidogen-1), which is a key ingredient in the skin's basement membrane and helps prevent aging, as well as lactic acid bacteria-derived exosome CHA-Probiotic EV Complex which helps whitening, anti-inflammatory, and skin barrier properties and skin epithelial growth factor (CHA-EGF).

CELLTERMI REVIVE Aftercare consists of three types. Among them, ‘Repair Cream’ is a regenerative cream that soothes and protects the weakened skin barrier after treatment. The repair cream contains powerful regenerative ingredients that help strengthen the skin barrier, including nidogen and EGF, which are independently developed ingredients, as well as CHA-Vitatide C, an antioxidant and ingredient that induces collagen synthesis. It also contains Arnica Montana extract, which relieves skin heat, and Adenosine, a notified ingredient in wrinkle-improving functional cosmetics.

CELLTERMI REVIVE Aftercare ‘Mella Cream’ is a complexion cream that helps prevent pigmentation and blemishes after skin care. Contains 'CHA-Probiotic EV Complex', an exosome extracted from three types of lactic acid bacteria that can help anti-inflammatory, whiten, and strengthen the skin barrier, and 'CHA-Zeromelatide', a patented peptide that inhibits melanin production, reducing pigmentation. It provide a new concept of preemptive care. It also contains Glutathione, which helps improve skin tone, and Niacinamide, a notified ingredient in whitening functional cosmetics, adding synergy to the skin whitening effect. Both products have completed skin irritation tests so that they can be used without burden even on sensitive skin after treatment, and are fragrance-free and odorless.

In addition to the two types of creams, the recently released CELLTERMI REVIVE Aftercare also includes a ‘Repair Soothing Mask’. This product contains proprietary ingredients included in the two creams and helps improve skin texture and tone. The repair soothing mask contains ▲Nidogen and CHA-EFG ingredients that induce skin regeneration and texture improvement ▲CHA-Probiotic EV Complex that cares for skin sensitive to stimulation ▲Niacinamide that helps with whitening function by taking care of melanin pigment. Stability testing has been completed, and the non-sticky, fast-absorbing formulation allows for easy self-care.

In addition to the previously released ‘CELLTERMI REVIVE’ topical skin booster, CHAMEDITECH has added an aftercare brand for post-treatment care, and now has a systematic product portfolio from cosmetics brands for hospitals and clinics.

Sokjin Kim, CEO of CHAMEDITECH, said, “Following Topical Skin Booster, CHAMEDITECH is solidifying its position in the medical aesthetics market by commercializing its own developed raw materials into cosmetics for hospitals and clinics.” He added, “CHAMEDITECH is continuously developing and commercializing materials. We will be a global leader in the development of biomaterials.”